A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients
- Conditions
- Human Epithelial Receptor (HER)-2 Positive Breast Cancer
- Interventions
- First Posted Date
- 2013-01-09
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- Biocad
- Target Recruit Count
- 225
- Registration Number
- NCT01764022
- Locations
- 🇧🇾
Brest Region Clinical Oncology Dispensary, Brest, Belarus
🇧🇾Gomel Region Clinical Oncology Dispensary, Gomel, Belarus
🇧🇾Grodno Regional Hospital, Grodno, Belarus
A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2013-01-09
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Biocad
- Target Recruit Count
- 353
- Registration Number
- NCT01763645
- Locations
- 🇧🇾
Brest Regional Clinical Dispensary, Brest, Belarus
🇧🇾Gomel Regional Clinical Oncology Dispensary, Gomel, Belarus
🇧🇾Grodno Regional Clinical Hospital, Grodno, Belarus
Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis
- First Posted Date
- 2013-01-02
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Biocad
- Target Recruit Count
- 181
- Registration Number
- NCT01759030
- Locations
- 🇧🇾
Gomel Regional Clinical Hospital, Gomel, Belarus
🇧🇾City Clinical Hospital №1, Minsk, Belarus
🇧🇾City Clinical Hospital №9, Minsk, Belarus
Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C
- Conditions
- HepatitisHepatitis C
- Interventions
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Biocad
- Target Recruit Count
- 150
- Registration Number
- NCT01740089
- Locations
- 🇷🇺
Moscow State University of Medicine and Dentistry, Moscow, Russian Federation
Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma
- Conditions
- Nodal Marginal Zone LymphomaSplenic Marginal Zone LymphomaFollicular Non-Hodgkin's Lymphoma
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Biocad
- Target Recruit Count
- 174
- Registration Number
- NCT01701232
- Locations
- 🇨🇴
Instituto Nacional de Cancerología, Bogotá, Colombia
🇨🇴Fundación Reina Isabel, Cali, Colombia
🇨🇴Hospital Pablo Tobon Uribe, Medellín, Colombia
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer
- Conditions
- Chemotherapy-induced Neutropenia
- First Posted Date
- 2012-04-02
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Biocad
- Target Recruit Count
- 60
- Registration Number
- NCT01569087
- Locations
- 🇷🇺
Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk, Russian Federation
🇷🇺Perm Region Oncology Dispensary, Perm, Russian Federation
🇷🇺N.N.Petrov Oncology Research Center, St.Petersburg, Russian Federation